North Texas Kidney Disease Associates
 

Our Patient Portal MyHealthRecord.com can be accessed here.

Message to our patients regarding COVID-19

 

We have temporarily transitioned our office practice to telemedicine visits only as we navigate the Coronavirus pandemic together.  

 

Patients with upcoming appointments will be contacted by our office to convert your in-person visits to a telemedicine visit.  These visits can be done with your physician from the comfort of your home and without risking exposure to the Coronavirus.

 

If you need a follow-up appointment, please call our office during office hours and we will schedule an appointment for you with your physician.

 

We are in unprecedented times and we want you to know we are here for you. There is nothing more important to us than your health and safety.

 

North Texas Kidney Disease Associates

Physicians and Staff

 

North Texas Kidney Disease Associates (NTKDA) offices of Baylor-Carrollton, Carrollton, Denton, Flower Mound, Frisco, Fort Worth, Keller, Lewisville, North Richland Hills and Plano have received recognition as a Patient-Centered Specialty Practice (PCSP) by The National Committee for Quality Assurance (NCQA). 

Earning NCQA Recognition shows that NTKDA has undergone a rigorous review of its capabilities and is committed to communication, coordination and providing access to care.  Recognition signals to primary care practices that North Texas Kidney Disease Associates is ready to be an effective partner in caring for patients they have in common.

Patient Education Classes:

NTKDA-color-logo-star-only-v1.png

Our Mission:

Our mission is to be the premier provider of comprehensive health care services for patients with kidney disease. We will deliver health care in a professional, compassionate and individualized manner designed to promote mutual respect and foster strong doctor-patient relationships.

Medical Tidbits:

June 15th
MedPage Today (6/14, Brown) reports that “the FDA is strengthening a warning on the labels of two diabetes drugs to reflect risk of acute kidney injuries.” The “new labels for the two sodium-glucose transport 2 (SGLT-2) drugs &ndash…